{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:31:29Z","timestamp":1793035889314,"version":"4.5.0"},"reference-count":97,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2023,6,22]],"date-time":"2023-06-22T00:00:00Z","timestamp":1687392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Currently, ovarian cancer (OC) is a target of intense biomarkers research because of its frequent late diagnosis and poor prognosis. Serum determination of Human epididymis protein 4 (HE4) is a very important early detection test. Most interestingly, HE4 plays a unique role in OC as it has been implicated not only in OC diagnosis but also in the prognosis and recurrence of this lethal neoplasm, actually acting as a clinical biomarker. There are several evidence about the predictive power of HE4 clinically, conversely less has been described concerning its role in OC oncogenesis. Based on these considerations, the main goal of this review is to clarify the role of HE4 in OC proliferation, angiogenesis, metastatization, immune response and also in the development of targeted therapy. Through a deeper understanding of its functions as a key molecule in the oncogenetic processes underlying OC, HE4 could be possibly considered as an essential resource not only for diagnosis but also for prognosis and therapy choice.<\/jats:p>","DOI":"10.3390\/ijms241310479","type":"journal-article","created":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T01:54:56Z","timestamp":1687485296000},"page":"10479","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Recent Insight about HE4 Role in Ovarian Cancer Oncogenesis"],"prefix":"10.3390","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-3219","authenticated-orcid":false,"given":"Emanuela","family":"Anastasi","sequence":"first","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8629-0971","authenticated-orcid":false,"given":"Antonella","family":"Farina","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Granato","sequence":"additional","affiliation":[{"name":"CNR-IBPM, Institute of Molecular Biology and Pathology, Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4887-7234","authenticated-orcid":false,"given":"Flavia","family":"Colaiacovo","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0121-433X","authenticated-orcid":false,"given":"Beatrice","family":"Pucci","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Tartaglione","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Angeloni","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2147\/IJWH.S197604","article-title":"Ovarian cancer in the world: Epidemiology and risk factors","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Int. J. Women\u2019s Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"188361","DOI":"10.1016\/j.bbcan.2020.188361","article-title":"Targeting tumor microenvironment in ovarian cancer: Premise and promise","volume":"1873","author":"Jiang","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Morand, S., Devanaboyina, M., Staats, H., Stanbery, L., and Nemunaitis, J. (2021). Ovarian Cancer Immunotherapy and Personalized Medicine. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126532"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.semcancer.2022.03.027","article-title":"Molecular, cellular and systemic aspects of epithelial ovarian cancer and its tumor microenvironment","volume":"86","author":"Schoutrop","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000529364","article-title":"Role of Fine Needle Aspiration Cytology in the Diagnosis of Gynecologic Tumors","volume":"67","author":"Goyal","year":"2023","journal-title":"Acta Cytol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/AOG.0000000000002580","article-title":"Ovarian Cancer Prevention and Screening","volume":"131","author":"Menon","year":"2018","journal-title":"Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.matbio.2023.02.004","article-title":"Extracellular matrix in high-grade serous ovarian cancer: Advances in understanding of carcinogenesis and cancer biology","volume":"118","author":"Brown","year":"2023","journal-title":"Matrix Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/ijc.28249","article-title":"Tubal ligation, hysterectomy and epithelial ovarian cancer in the New England Case-Control Study","volume":"133","author":"Rice","year":"2013","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrc.2016.113","article-title":"The disparate origins of ovarian cancers: Pathogenesis and prevention strategies","volume":"17","author":"Karnezis","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/PGP.0b013e3181f29d2a","article-title":"The Fallopian Tube-Peritoneal Junction: A potential site of carcinogenesis","volume":"30","author":"Seidman","year":"2011","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4274\/jtgga.galenos.2018.2018.0119","article-title":"Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery","volume":"20","author":"Budiana","year":"2019","journal-title":"J. Turk. Gynecol. Assoc."},{"key":"ref_12","first-page":"e30561","article-title":"Aetiology, Epidemiology, Histopathology, Classification, Detailed Evaluation, and Treatment of Ovarian Cancer","volume":"14","author":"Zamwar","year":"2022","journal-title":"Cureus"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Englisz, A., Smycz-Kuba\u0144ska, M., and Mielczarek-Palacz, A. (2023). Evaluation of the Potential Diagnostic Utility of the Determination of Selected Immunological and Molecular Parameters in Patients with Ovarian Cancer. Diagnostics, 13.","DOI":"10.3390\/diagnostics13101714"},{"key":"ref_14","first-page":"454","article-title":"Ovarian cancer--modern approach to its origin and histogenesis","volume":"83","year":"2012","journal-title":"Ginekol. Polska"},{"key":"ref_15","first-page":"e38273","article-title":"Histomorphological Analysis of Ovarian Neoplasms According to the 2020 WHO Classification of Ovarian Tumors: A Distribution Pattern in a Tertiary Care Center","volume":"15","author":"Mehra","year":"2023","journal-title":"Cureus"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"K\u00f6bel, M., and Kang, E.Y. (2022). The Evolution of Ovarian Carcinoma Subclassification. Cancers, 14.","DOI":"10.3390\/cancers14020416"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An Integrated Review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3233\/TUB-211557","article-title":"CT imaging phenotypes linked to CA125 and HE4 biomarkers are highly predictive in discriminating between hereditary and sporadic ovarian cancer patients","volume":"44","author":"Manganaro","year":"2022","journal-title":"Tumor Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"djv214","DOI":"10.1093\/jnci\/djv214","article-title":"Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer","volume":"107","author":"Ramus","year":"2015","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"50930","DOI":"10.18632\/oncotarget.15871","article-title":"Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene","volume":"8","author":"Dicks","year":"2017","journal-title":"Oncotarget"},{"key":"ref_21","unstructured":"National Cancer Institute (2023, April 28). Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Ovarian Cancer, Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1002\/cncr.29321","article-title":"Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer","volume":"121","author":"Walker","year":"2015","journal-title":"Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1177\/0300060518792801","article-title":"Association between dietary fiber intake and risk of ovarian cancer: A meta-analysis of observational studies","volume":"46","author":"Huang","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_24","unstructured":"Cancer Research, UK (2023, April 28). Ovarian Cancer Risk Factors. Available online: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer\/risk-factors."},{"key":"ref_25","unstructured":"Schenken, R.S. (2023, April 28). Endometriosis: Pathogenesis, Epidemiology, and Clinical Impact. Available online: https:\/\/www.uptodate.com\/contents\/endometriosis-pathogenesis-epidemiology-and-clinical-impact."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Angeloni, A., De Vito, C., Farina, A., Terracciano, D., Cennamo, M., Passerini, R., Bottari, F., Schirinzi, A., Vettori, R., and Steffan, A. (2022). New Analytical Approach for the Alignment of Different HE4 Automated Immunometric Systems: An Italian Multicentric Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11071994"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Chudecka-G\u0142az, A., Strojna, A., Michalczyk, K., Wieder-Huszla, S., Safranow, K., Skwirczy\u0144ska, E., and Jurczak, A. (2023). Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy. Diagnostics, 13.","DOI":"10.3390\/diagnostics13030452"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Zalfa, F., Perrone, M.G., Ferorelli, S., Laera, L., Pierri, C.L., Tolomeo, A., Dimiccoli, V., Perrone, G., De Grassi, A., and Scilimati, A. (2022). Genome-Wide Identification and Validation of Gene Expression Biomarkers in the Diagnosis of Ovarian Serous Cystadenocarcinoma. Cancers, 14.","DOI":"10.3390\/cancers14153764"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1095\/biolreprod45.2.350","article-title":"A Major Human Epididymis-Specific cDNA Encodes a Protein with Sequence Homology to Extracellular Proteinase Inhibitors1","volume":"45","author":"Kirchhoff","year":"1991","journal-title":"Biol. Reprod."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9339325","DOI":"10.1155\/2022\/9339325","article-title":"A Clinical Diagnostic Value Analysis of Serum CA125, CA199, and HE4 in Women with Early Ovarian Cancer: Systematic Review and Meta-Analysis","volume":"2022","author":"Qing","year":"2022","journal-title":"Comput. Math. Methods Med."},{"key":"ref_31","first-page":"3695","article-title":"The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma","volume":"63","author":"Raycraft","year":"2003","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cca.2015.03.047","article-title":"HE4 in the differential diagnosis of ovarian masses","volume":"446","author":"Granato","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s13277-010-0049-1","article-title":"Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women","volume":"31","author":"Anastasi","year":"2010","journal-title":"Tumor Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1746-1596-8-11","article-title":"Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response","volume":"8","author":"Hamed","year":"2013","journal-title":"Diagn. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2008.08.031","article-title":"A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass","volume":"112","author":"Moore","year":"2009","journal-title":"Gynecol. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Cvii\u010d, D., Jagarlamudi, K., Megli\u010d, L., \u0160kof, E., Zore, A., Lukanovi\u0107, D., Eriksson, S., and Osredkar, J. (2023). A Dual Biomarker TK1 Protein and CA125 or HE4-Based Algorithm as a Better Diagnostic Tool than ROMA Index in Early Detection of Ovarian Cancer. Cancers, 15.","DOI":"10.3390\/cancers15051593"},{"key":"ref_37","first-page":"6341","article-title":"Biparametric Magnetic Resonance Imaging as an Adjunct to CA125 and HE4 to Improve Characterization of Large Ovarian Masses","volume":"35","author":"Manganaro","year":"2015","journal-title":"Anticancer. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14737159.2018.1457436","article-title":"Prognostic value of serum and tissue HE4 expression in ovarian cancer: A systematic review with meta-analysis of 90 studies","volume":"18","author":"Cao","year":"2018","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3233\/TUB-220016","article-title":"HE4 and CA125 serum biomarker monitoring in women with epithelial ovarian cancer","volume":"44","author":"Samborski","year":"2022","journal-title":"Tumor Biol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Plotti, F., Terranova, C., Guzzo, F., Nardone, C.D.C., Luvero, D., Bartolone, M., Dionisi, C., Benvenuto, D., Fabris, S., and Ciccozzi, M. (2021). Role of BRCA Mutation and HE4 in Predicting Chemotherapy Response in Ovarian Cancer: A Retrospective Pilot Study. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010055"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fonc.2018.00124","article-title":"Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer","volume":"8","author":"James","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"729","DOI":"10.18632\/oncotarget.6327","article-title":"Overexpression of HE4 (human epididymis protein 4) enhances proliferation, invasion and metastasis of ovarian cancer","volume":"7","author":"Zhu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3109\/10799893.2015.1030412","article-title":"Signaling pathway of MAPK\/ERK in cell proliferation, differentiation, migration, senescence and apoptosis","volume":"35","author":"Sun","year":"2015","journal-title":"J. Recept. Signal Transduct."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1995-7645(13)60055-3","article-title":"Effect of WFDC 2 silencing on the proliferation, motility and invasion of human serous ovarian cancer cells in vitro","volume":"6","author":"Zhu","year":"2013","journal-title":"Asian Pac. J. Trop. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/jog.13181","article-title":"Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer","volume":"43","author":"Lee","year":"2017","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13048-016-0240-0","article-title":"HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells","volume":"9","author":"Ribeiro","year":"2016","journal-title":"J. Ovarian Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1745-7270.2005.00076.x","article-title":"Regulation of EGF-induced ERK\/MAPK Activation and EGFR Internalization by G Protein-coupled Receptor Kinase 2","volume":"37","author":"Gao","year":"2005","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ceb.2017.02.007","article-title":"PI3K signaling in cancer: Beyond AKT","volume":"45","author":"Lien","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"108044","DOI":"10.1016\/j.abb.2019.07.009","article-title":"HDAC3 positively regulates HE4 expression to promote ovarian carcinoma progression","volume":"675","author":"Lou","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Korbecki, J., Simi\u0144ska, D., G\u0105ssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., and Baranowska-Bosiacka, I. (2021). Chronic and Cycling Hypoxia: Drivers of Cancer Chronic Inflammation through HIF-1 and NF-\u03baB Activation: A Review of the Molecular Mechanisms. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221910701"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood-2007-10-115758","article-title":"HIF-1\u03b1 regulates epithelial inflammation by cell autonomous NF\u03baB activation and paracrine stromal remodeling","volume":"111","author":"Scortegagna","year":"2008","journal-title":"Blood"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1038\/srep03574","article-title":"HE4 (WFDC2) gene overexpression promotes ovarian tumor growth","volume":"4","author":"Moore","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Jin, W. (2020). Role of JAK\/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition. Cells, 9.","DOI":"10.3390\/cells9010217"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"bio043570","DOI":"10.1242\/bio.043570","article-title":"Knockdown of HE4 suppresses aggressive cell growth and malignant progression of ovarian cancer by inhibiting the JAK\/STAT3 pathway","volume":"8","author":"Wang","year":"2019","journal-title":"Biol. Open"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3892\/or.2014.3549","article-title":"Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells","volume":"33","author":"Wang","year":"2015","journal-title":"Oncol. Rep."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.bbrc.2012.02.008","article-title":"Human epididymis protein 4 (HE4) plays a key role in ovarian cancer cell adhesion and motility","volume":"419","author":"Lu","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"8558","DOI":"10.1038\/s41598-020-65353-x","article-title":"The biomarker HE4 (WFDC2) promotes a pro-angiogenic and immunosuppressive tumor microenvironment via regulation of STAT3 target genes","volume":"10","author":"James","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.oraloncology.2018.04.005","article-title":"The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis","volume":"82","author":"Tam","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e020014","DOI":"10.1136\/bmjopen-2017-020014","article-title":"Head and neck cancer risk factors in India: Protocol for systematic review and meta-analysis","volume":"8","author":"Poddar","year":"2018","journal-title":"BMJ Open"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.oraloncology.2018.08.003","article-title":"Risk-reductive dental strategies for medication related osteonecrosis of the jaw among cancer patients: A systematic review with meta-analyses","volume":"85","author":"Karna","year":"2018","journal-title":"Oral Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1751-1097.2011.01062.x","article-title":"mTHPC-mediated Photodynamic Treatment Up-regulates the Cytokines VEGF and IL-1alpha","volume":"88","author":"Dabkeviciene","year":"2012","journal-title":"Photochem. Photobiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"29762","DOI":"10.1038\/srep29762","article-title":"Persisting and Increasing Neutrophil Infiltration Associates with Gastric Carcinogenesis and E-cadherin Downregulation","volume":"6","author":"Fu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.ajpath.2011.05.031","article-title":"Tumor-Recruited Neutrophils and Neutrophil TIMP-Free MMP-9 Regulate Coordinately the Levels of Tumor Angiogenesis and Efficiency of Malignant Cell Intravasation","volume":"179","author":"Bekes","year":"2011","journal-title":"Am. J. Pathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13287-022-02742-1","article-title":"A dual role of HIF1\u03b1 in regulating osteogenesis\u2013angiogenesis coupling","volume":"13","author":"Shao","year":"2022","journal-title":"Stem Cell Res. Ther."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nm0603-677","article-title":"Regulation of angiogenesis by hypoxia: Role of the HIF system","volume":"9","author":"Pugh","year":"2003","journal-title":"Nat. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.omto.2018.11.004","article-title":"Hypoxia-Induced Upregulation of HE4 Is Responsible for Resistance to Radiation Therapy of Gastric Cancer","volume":"12","author":"Peng","year":"2019","journal-title":"Mol. Ther. Oncolytics"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0968-0004(98)01344-9","article-title":"Oncogenic alterations of metabolism","volume":"24","author":"Dang","year":"1999","journal-title":"Trends Biochem. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Amer, H., Kartikasari, A.E.R., and Plebanski, M. (2021). Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11121335"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/08820139.2017.1360342","article-title":"Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer","volume":"46","author":"Sanguinete","year":"2017","journal-title":"Immunol. Investig."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.bbrc.2019.11.011","article-title":"WFDC2 gene deletion in mouse led to severe dyspnea and type-I alveolar cell apoptosis","volume":"522","author":"Zhang","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","first-page":"2583","article-title":"Combinatorial therapy of immune checkpoint and cancer pathways provides a novel perspective on ovarian cancer treatment","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.21873\/anticanres.13380","article-title":"Diagnostic Power of Selected Cytokines, MMPs and TIMPs in Ovarian Cancer Patients\u2014ROC Analysis","volume":"39","author":"Gacuta","year":"2019","journal-title":"Anticancer. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"842002","DOI":"10.3389\/fmed.2022.842002","article-title":"The Role of Human Epididymis Protein 4 in the Diagnosis and Prognosis of Diseases: An Umbrella Review of Systematic Reviews and Meta-Analyses of Observational Studies","volume":"9","author":"Sun","year":"2022","journal-title":"Front. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.7150\/jca.62440","article-title":"Interaction of CD147 and human epididymis protein 4 promotes invasion and metastasis of ovarian cancer","volume":"12","author":"Gao","year":"2021","journal-title":"J. Cancer"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2018.02.013","article-title":"Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment","volume":"196","author":"Ballestar","year":"2018","journal-title":"Clin. Immunol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1177\/147323001103900507","article-title":"The Role of HE4 in Ovarian Cancer: Inhibiting Tumour Cell Proliferation and Metastasis","volume":"39","author":"Gao","year":"2011","journal-title":"J. Int. Med. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ijgo.13140","article-title":"HE 4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer","volume":"149","author":"Romera","year":"2020","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.biochi.2014.06.022","article-title":"Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells","volume":"105","author":"Zhuang","year":"2014","journal-title":"Biochimie"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1465-9921-7-61","article-title":"WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung","volume":"7","author":"Bingle","year":"2006","journal-title":"Respir. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3389\/fimmu.2020.00940","article-title":"The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses","volume":"11","author":"Loskog","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.4049\/jimmunol.2000281","article-title":"HE4 Overexpression by Ovarian Cancer Promotes a Suppressive Tumor Immune Microenvironment and Enhanced Tumor and Macrophage PD-L1 Expression","volume":"206","author":"Singh","year":"2021","journal-title":"J. Immunol."},{"key":"ref_83","unstructured":"Dubey, W.B.H., Modi, M., Verma, S., Sinha, R., Goel, H., Ranjan, A., Tanwar, P., Chopra, A., Rahul, E., and Ranjan, L. (2023). Recent Advances, New Perspectives and Applications in the Treatment of Ovarian Cancer, IntechOpen."},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Li, R., Xu, J., Wu, M., Liu, S., Fu, X., Shang, W., Wang, T., Jia, X., and Wang, F. (2023). Circulating CD4+ Treg, CD8+ Treg, and CD3+ \u03b3\u03b4 T Cell Subpopulations in Ovarian Cancer. Medicina, 59.","DOI":"10.3390\/medicina59020205"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Liu, P., Chen, R., Zhang, X., Fu, R., Tao, L., and Jia, W. (2022). Combined PD-1\/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma. BMC Genom., 23.","DOI":"10.1186\/s12864-021-08265-y"},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Saffarieh, E., Nassiri, S., and Mirmohammadkhani, M. (2022). Predicting value of HE4 and CA125 markers for optimal cytoreductive surgery in ovarian cancer patients. Eur. J. Transl. Myol., 32.","DOI":"10.4081\/ejtm.2022.10671"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Chakraborty, S., Shenoy, P.S., Mehrotra, M., Phadte, P., Singh, P., Rekhi, B., and Ray, P. (2023). Through the Looking Glass: Updated Insights on Ovarian Cancer Diagnostics. Diagnostics, 13.","DOI":"10.3390\/diagnostics13040713"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.3390\/cimb45020081","article-title":"Immunotherapeutic Approaches in Ovarian Cancer","volume":"45","author":"Yoon","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1007\/s13277-014-1836-x","article-title":"Can HE4 predict platinum response during first-line chemotherapy in ovarian cancer?","volume":"35","author":"Angioli","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.clinthera.2018.01.012","article-title":"Use of Targeted Therapeutics in Epithelial Ovarian Cancer: A Review of Current Literature and Future Directions","volume":"40","author":"Vetter","year":"2018","journal-title":"Clin. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Lisio, M.-A., Fu, L., Goyeneche, A., Gao, Z.-H., and Telleria, C. (2019). High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20040952"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1757-2215-5-34","article-title":"Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis","volume":"5","author":"Lane","year":"2012","journal-title":"J. Ovarian Res."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Carey, P., Low, E., Harper, E., and Stack, M.S. (2021). Metalloproteinases in Ovarian Cancer. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22073403"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"G\u0105sowska-Bajger, B., G\u0105sowska-Bodnar, A., Knapp, P., and Bodnar, L. (2021). Prognostic Significance of Survivin Expression in Patients with Ovarian Carcinoma: A Meta-Analysis. J. Clin. Med., 10.","DOI":"10.3390\/jcm10040879"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jmig.2017.03.014","article-title":"Impact of Surgical Route in Influencing the Risk of Lymphatic Complications After Ovarian Cancer Staging","volume":"24","author":"Bogani","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"76","DOI":"10.36129\/jog.2022.34","article-title":"The role of preoperative frailty assessment in patients affected by gynecological cancer: A narrative review","volume":"34","author":"Baiocco","year":"2022","journal-title":"Ital. J. Gynaecol. Obstet."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.2147\/CMAR.S366681","article-title":"Towards Personalized Management of Ovarian Cancer","volume":"14","author":"Algethami","year":"2022","journal-title":"Cancer Manag. Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/10479\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:58:28Z","timestamp":1760126308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/13\/10479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,22]]},"references-count":97,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["ijms241310479"],"URL":"https:\/\/doi.org\/10.3390\/ijms241310479","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,22]]}}}